The "New Trends in Virtual Screening" special issue edited by Professor Renxiao Wang from the Department of Medicinal C...
Cardiovascular disease (CVD) is a leading cause of death and loss of productive life years worldwide1. Atherosclerosis ...
A novel liposome-leukocytes combination delivery system was designed for ischemic stroke target therapy. The study was ...
Recently, Lu Zhou's lab from School of Pharmacy, Fudan University, has published a paper entitled "A novel allosteric i...
Recently, Professor Wei Lu from School of Pharmacy, Fudan University, has designed a new theranostic preparation using ...
Vision has profound influence on the quality of life. Up to now, the number of visually impaired patients worldwide is ...
Recently, Professor Wei Lu from School of Pharmacy, Fudan University, has used biomimetic technology to prepare an adju...
With the support of National Science Fund for Distinguished Young Scholars and National Natural Science Foundation of C...
Recently, the team of Professor Xiaoyan Shen (School of Pharmacy, Fudan University) in collaboration with the team of Z...
Recently, Di Zhu, professor at the School of Pharmacy, and Yuxiong Feng, professor at Zhejiang University, have made ne...
The limited chemotherapy effect of pancreatic cancer is related to its unique and complex tumor microenvironment (TME)....
Metastasis is the major cause of high mortality in cancer patients, thus metastasis suppression is the key and most cha...
Recently, Professor Wei Lu of the School of Pharmacy, Fudan University and Professor Zeyu Xiao of the School of Medicin...
Teams from Fudan University (Prof. Weiyue Lu’s lab) and University of California, San Diego (Prof. Liangfang Zhang’s ...
Epigenetic alteration like DNA hypermethylation plays a pivotal role in immune evasion of cancer cells during tumorigen...
Recently, Professor Chen Jiang’s group from Fudan University School of Pharmacy developed a polymeric micelle drug del...
Recently, Professor Chen Jiang’s group from Fudan University School of Pharmacy developed a new type of prodrug-loaded...
Triple-negative breast cancer (TNBC) is an extremely hard-to-treat subtype (~15%) of breast cancer. As TNBC lacks expre...
Recently, the research about a novel smart anti-tumor nanomedicine was published online in Advanced Functional Material...